MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Blood
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

10,018 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
10,018 works in the cohort · of 4,299,418page 21 of 201

Labels cover 11 of 10,018 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 10,018 of 10,018 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network Trial
Mark R. Litzow, Zhuoxin Sun, Elisabeth Paietta, Ryan J. Mattison, Hillard M. Lazarus, Jacob M. Rowe +19 more
2022· article· en· Blood· Medicine
machine prediction:candidate · noneconsensus · none
75
citations
affunlabeled
Mutations in the SBDS gene in acquired aplastic anemia
Rodrigo T. Calado, Solomon A. Graf, Keisha L. Wilkerson, Sachiko Kajigaya, Philip Ancliff, Yigal Dror +3 more
2007· article· en· Blood· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
75
citations
affunlabeled
The Tao of myeloma
Lawrence Boise, Jonathan L. Kaufman, Nizar J. Bahlis, Sagar Lonial, Kelvin P. Lee
2014· review· en· Blood· Medicine
machine prediction:candidate · noneconsensus · none
72
citations
fundno affunlabeled
Novel treatment concepts for graft-versus-host disease
Dominik Wolf‎, Marie von Lilienfeld‐Toal, Anna Wolf, Michael Schleuning, Michael von Bergwelt‐Baildon, Stefanie AE Held +1 more
2011· review· en· Blood· Medicine
machine prediction:candidate · noneconsensus · none
72
citations

How this was built: Screen · Findings · About